145 related articles for article (PubMed ID: 31876386)
1. TM4SF1, a binding protein of DVL2 in hepatocellular carcinoma, positively regulates beta-catenin/TCF signalling.
Zhu C; Luo X; Wu J; Liu Y; Liu L; Ma S; Xie R; Wang S; Ji W
J Cell Mol Med; 2021 Mar; 25(5):2356-2364. PubMed ID: 31876386
[TBL] [Abstract][Full Text] [Related]
2. CYP2E1 plays a suppressive role in hepatocellular carcinoma by regulating Wnt/Dvl2/β-catenin signaling.
Zhu L; Yang X; Feng J; Mao J; Zhang Q; He M; Mi Y; Mei Y; Jin G; Zhang H
J Transl Med; 2022 May; 20(1):194. PubMed ID: 35509083
[TBL] [Abstract][Full Text] [Related]
3. Cripto-1 contributes to stemness in hepatocellular carcinoma by stabilizing Dishevelled-3 and activating Wnt/β-catenin pathway.
Lo RC; Leung CO; Chan KK; Ho DW; Wong CM; Lee TK; Ng IO
Cell Death Differ; 2018 Aug; 25(8):1426-1441. PubMed ID: 29445127
[TBL] [Abstract][Full Text] [Related]
4. DIAPH3 promoted the growth, migration and metastasis of hepatocellular carcinoma cells by activating beta-catenin/TCF signaling.
Dong L; Li Z; Xue L; Li G; Zhang C; Cai Z; Li H; Guo R
Mol Cell Biochem; 2018 Jan; 438(1-2):183-190. PubMed ID: 28795316
[TBL] [Abstract][Full Text] [Related]
5. CARF activates beta-catenin/TCF signaling in the hepatocellular carcinoma.
Fan X; Ma X; Cui L; Dang S; Qu J; Zhang J; Wang X; Mao Z
Oncotarget; 2016 Dec; 7(49):80404-80414. PubMed ID: 27829235
[TBL] [Abstract][Full Text] [Related]
6. Curcumin suppresses proliferation and induces apoptosis of human hepatocellular carcinoma cells via the wnt signaling pathway.
Xu MX; Zhao L; Deng C; Yang L; Wang Y; Guo T; Li L; Lin J; Zhang L
Int J Oncol; 2013 Dec; 43(6):1951-9. PubMed ID: 24064724
[TBL] [Abstract][Full Text] [Related]
7. CDK7 activated beta-catenin/TCF signaling in hepatocellular carcinoma.
Duan J; He Y; Fu X; Deng Y; Zheng M; Lu D
Exp Cell Res; 2018 Sep; 370(2):461-467. PubMed ID: 29981747
[TBL] [Abstract][Full Text] [Related]
8. HIF-1α-activated TM4SF1-AS1 promotes the proliferation, migration, and invasion of hepatocellular carcinoma cells by enhancing TM4SF1 expression.
Zeng Z; Shi Z; Liu Y; Zhao J; Lu Q; Guo J; Liu X; Huang D; Xu Q
Biochem Biophys Res Commun; 2021 Aug; 566():80-86. PubMed ID: 34118595
[TBL] [Abstract][Full Text] [Related]
9. PKMYT1 promoted the growth and motility of hepatocellular carcinoma cells by activating beta-catenin/TCF signaling.
Liu L; Wu J; Wang S; Luo X; Du Y; Huang D; Gu D; Zhang F
Exp Cell Res; 2017 Sep; 358(2):209-216. PubMed ID: 28648520
[TBL] [Abstract][Full Text] [Related]
10. STIP1 is over-expressed in hepatocellular carcinoma and promotes the growth and migration of cancer cells.
Luo X; Liu Y; Ma S; Liu L; Xie R; Li M; Shen P; Wang S
Gene; 2018 Jul; 662():110-117. PubMed ID: 29596884
[TBL] [Abstract][Full Text] [Related]
11. Liver cancer: WISP3 suppresses hepatocellular carcinoma progression by negative regulation of β-catenin/TCF/LEF signalling.
Gao H; Yin FF; Guan DX; Feng YX; Zheng QW; Wang X; Zhu M; Zhang XL; Cheng SQ; Chen TW; Jiang H; Zhang EB; Wang JJ; Ni QZ; Yuan YM; Zhang FK; Ma N; Cao HJ; Wang YK; Li JJ; Xie D
Cell Prolif; 2019 May; 52(3):e12583. PubMed ID: 30793395
[TBL] [Abstract][Full Text] [Related]
12. WDR34 Activates Wnt/Beta-Catenin Signaling in Hepatocellular Carcinoma.
Luo X; Liu Y; Ma S; Liu L; Xie R; Wang S
Dig Dis Sci; 2019 Sep; 64(9):2591-2599. PubMed ID: 30877610
[TBL] [Abstract][Full Text] [Related]
13. ASPM promotes hepatocellular carcinoma progression by activating Wnt/β-catenin signaling through antagonizing autophagy-mediated Dvl2 degradation.
Zhang H; Yang X; Zhu L; Li Z; Zuo P; Wang P; Feng J; Mi Y; Zhang C; Xu Y; Jin G; Zhang J; Ye H
FEBS Open Bio; 2021 Oct; 11(10):2784-2799. PubMed ID: 34428354
[TBL] [Abstract][Full Text] [Related]
14. microRNA-520f inhibits hepatocellular carcinoma cell proliferation and invasion by targeting TM4SF1.
Du X; Fan W; Chen Y
Gene; 2018 May; 657():30-38. PubMed ID: 29505836
[TBL] [Abstract][Full Text] [Related]
15. LRP16 prevents hepatocellular carcinoma progression through regulation of Wnt/β-catenin signaling.
Shao L; Jing W; Wang L; Pan F; Wu L; Zhang L; Yang P; Hu M; Fan K
J Mol Med (Berl); 2018 Jun; 96(6):547-558. PubMed ID: 29748698
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of dishevelled 2 is involved in tumor metastasis and is associated with poor prognosis in hepatocellular carcinoma.
Zhang C; Li C; Chen X; Zhou Y; Yin B; Ni R; Zhang Y; Liu J
Clin Transl Oncol; 2017 Dec; 19(12):1507-1517. PubMed ID: 28589433
[TBL] [Abstract][Full Text] [Related]
17. The microtubule-associated protein PRC1 promotes early recurrence of hepatocellular carcinoma in association with the Wnt/β-catenin signalling pathway.
Chen J; Rajasekaran M; Xia H; Zhang X; Kong SN; Sekar K; Seshachalam VP; Deivasigamani A; Goh BK; Ooi LL; Hong W; Hui KM
Gut; 2016 Sep; 65(9):1522-34. PubMed ID: 26941395
[TBL] [Abstract][Full Text] [Related]
18. Proliferation and migration mediated by Dkk-1/Wnt/beta-catenin cascade in a model of hepatocellular carcinoma cells.
Qin X; Zhang H; Zhou X; Wang C; Zhang H; Zhang X; Ye L
Transl Res; 2007 Nov; 150(5):281-94. PubMed ID: 17964517
[TBL] [Abstract][Full Text] [Related]
19. Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma.
Yamashita T; Budhu A; Forgues M; Wang XW
Cancer Res; 2007 Nov; 67(22):10831-9. PubMed ID: 18006828
[TBL] [Abstract][Full Text] [Related]
20. Prickle-1 negatively regulates Wnt/beta-catenin pathway by promoting Dishevelled ubiquitination/degradation in liver cancer.
Chan DW; Chan CY; Yam JW; Ching YP; Ng IO
Gastroenterology; 2006 Oct; 131(4):1218-27. PubMed ID: 17030191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]